|
UTP23 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.67321712041257E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.0176083026513E-12 |
| Normal-vs-Stage2 |
2.6645996520358E-10 |
| Normal-vs-Stage3 |
2.99760216648792E-15 |
| Normal-vs-Stage4 |
3.33066907387547E-16 |
| Stage1-vs-Stage2 |
9.405000E-01 |
| Stage1-vs-Stage3 |
3.480400E-02 |
| Stage1-vs-Stage4 |
1.963270E-03 |
| Stage2-vs-Stage3 |
1.399040E-01 |
| Stage2-vs-Stage4 |
2.740300E-02 |
| Stage3-vs-Stage4 |
3.207800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.11972669919669E-14 |
| Normal-vs-AfricanAmerican |
2.43340000039005E-07 |
| Normal-vs-Asian |
1.77900028042188E-10 |
| Caucasian-vs-AfricanAmerican |
6.168200E-01 |
| Caucasian-vs-Asian |
2.928400E-01 |
| AfricanAmerican-vs-Asian |
8.089600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.32986979603811E-15 |
| Normal-vs-Female |
1.76214598468505E-12 |
| Male-vs-Female |
1.088960E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.97086791331458E-12 |
| Normal-vs-Age(41-60Yrs) |
3.65263375101677E-14 |
| Normal-vs-Age(61-80Yrs) |
1.66044955562938E-12 |
| Normal-vs-Age(81-100Yrs) |
5.5170999999965E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.323600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.240800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.175600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.469600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.761800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.476600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.427000E-04 |
| Classical-VS-Follicular |
2.212000E-01 |
| Classical-VS-Other |
3.972400E-01 |
| Classical-VS-Normal |
7.13928915985207E-12 |
| Tall-VS-Follicular |
4.814000E-02 |
| Tall-VS-Other |
7.176200E-01 |
| Tall-VS-Normal |
1.63102864547682E-12 |
| Follicular-VS-Other |
6.986400E-01 |
| Follicular-VS-Normal |
1.63558055987778E-12 |
| Other-VS-Normal |
4.551400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.19904086659517E-14 |
| N0-vs-N1 |
1.207180E-01 |
|
|
